Skip to main content
SpringerLink
Log in

Inflammatory Disorders of the Cutaneous Appendages

  • Chapter
  • First Online:
Pediatric Dermatopathology

  • 1682 Accesses

Abstract

Inflammatory infiltrates centered on eccrine and apocrine structures and pilosebaceous units give rise to a range of cutaneous disorders.   These conditions range from alopecia to acne vulgaris to blistering diseases of childhood, all of which have in common a peri-appendageal inflammatory infiltrate. The varying cell types and location of the infiltrates result in a wide range of cutaneous disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Antaya RJ, Robinson DM. Blisters and pustules in the newborn. Pediatr Ann. 2010;39(10):635–45.

    Article  PubMed  Google Scholar 

  2. Engur D, Turkmen MK, Savk E. Widespread miliaria crystallina in a newborn with hypernatremic dehydration. Pediatr Dermatol. 2013;30(6):e234–5.

    Article  PubMed  Google Scholar 

  3. Straka BF, Cooper PH, Greer KE. Congenital miliaria crystallina. Cutis. 1991;47(2):103–6.

    CAS  PubMed  Google Scholar 

  4. Holzle E, Kligman AM. The pathogenesis of miliaria rubra. Role of the resident microflora. Br J Dermatol. 1978;99(2):117–37.

    Article  CAS  PubMed  Google Scholar 

  5. Doshi BR, Mahajan S, Kharkar V, Khopkar US. Granulomatous variant of giant centrifugal miliaria profunda. Pediatr Dermatol. 2013;30(4):e48–51.

    Article  PubMed  Google Scholar 

  6. Rogers M, Kan A, Stapleton K, Kemp A. Giant centrifugal miliaria profunda. Pediatr Dermatol. 1990;7(2):140–6.

    Article  CAS  PubMed  Google Scholar 

  7. Armstrong L, Hubbard R, Epstein Y, Weien R. Nonconventional remission of miliaria rubra during heat acclimation: a case report. Mil Med. 1988;153(8):402–4.

    CAS  PubMed  Google Scholar 

  8. Doshi BR, Mahajan S, Kharkar V, Khopkar US. Granulomatous variant of giant centrifugal miliaria profunda. Pediatr Dermatol. 2012;30(4):e48–51.

    Article  PubMed  Google Scholar 

  9. Kirk JF, Wilson BB, Chun W, Cooper PH. Miliaria profunda. J Am Acad Dermatol. 1996;35(5 Pt 2):854–6.

    Article  CAS  PubMed  Google Scholar 

  10. Ferrándiz C, Coroleu W, Ribera M, Lorenzo JC, Natal A. Sterile transient neonatal pustulosis is a precocious form of erythema toxicum neonatorum. Dermatology. 1992;185(1):18–22.

    Article  PubMed  Google Scholar 

  11. Marchini G, Ulfgren AK, Loré K, Ståbi B, Berggren V, Lonne-Rahm S. Erythema toxicum neonatorum: an immunohistochemical analysis. Pediatr Dermatol. 2001;18(3):177–87.

    Article  CAS  PubMed  Google Scholar 

  12. Coroleu Lletget W, Natal Pujol A, Ferrándiz Foraster C, Prats Viñas J. Transient neonatal pustular melanosis. Anales Españoles De Pediatría. 1990;33(2):117–9.

    CAS  PubMed  Google Scholar 

  13. Ferrandiz C, Coroleu W, Ribera M, Lorenzo JC, Natal A. Sterile transient neonatal pustulosis is a precocious form of erythema toxicum neonatorum. Dermatology. 1992;185(1):18–22.

    Article  CAS  PubMed  Google Scholar 

  14. Monteagudo B, Labandeira J, Cabanillas M, Acevedo A, Toribio J. Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors. Pediatr Dermatol. 2011;29(2):166–8.

    Article  PubMed  Google Scholar 

  15. Boralevi F. Erythema toxicum neonatorum: still a problem in 2005? Dermatology. 2005;210(4):257–8.

    Article  PubMed  Google Scholar 

  16. Berk DR, Bayliss SJ. Milia: a review and classification. J Am Acad Dermatol. 2008;59(6):1050–63.

    Article  PubMed  Google Scholar 

  17. Epstein W, Kligman AM. The pathogenesis of milia and benign tumors of the skin. J Invest Dermatol. 1956;26(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  18. Honda Y, Egawa K, Baba Y, Ono T. Sweat duct milia—immunohistological analysis of structure and three-dimensional reconstruction. Arch Dermatol Res. 1996;288(3):133–9.

    CAS  PubMed  Google Scholar 

  19. Eichenfield LF, Krakowski AC, Piggott C, Del Rosso J, Baldwin H, Friedlander SF, Levy M, Lucky A, Mancini AJ, Orlow SJ, Yan AC, Vaux KK, Webster G, Zaenglein AL, Thiboutot DM. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131 Suppl 3:S163–86.

    Article  PubMed  Google Scholar 

  20. Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol. 1999;38(2):128–30.

    Article  CAS  PubMed  Google Scholar 

  21. Mengesha YM, Bennett ML. Pustular skin disorders: diagnosis and treatment. Am J Clin Dermatol. 2002;3(6):389–400.

    Article  PubMed  Google Scholar 

  22. Forest MG, Cathiard AM, Bertrand JA. Evidence of testicular activity in early infancy. J Clin Endocrinol Metab. 1973;37(1):148–51.

    Article  CAS  PubMed  Google Scholar 

  23. Jansen T, Burgdorf WH, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol. 1997;14(1):17–21.

    Article  CAS  PubMed  Google Scholar 

  24. Lucky AW. A review of infantile and pediatric acne. Dermatology. 1998;196(1):95–7.

    Article  CAS  PubMed  Google Scholar 

  25. Rapelanoro R, Mortureux P, Couprie B, Maleville J, Taieb A. Neonatal Malassezia furfur pustulosis. Arch Dermatol. 1996;132(2):190–3.

    Article  CAS  PubMed  Google Scholar 

  26. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39(2 Pt 3):S34–7.

    Article  CAS  PubMed  Google Scholar 

  27. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474–85.

    Article  CAS  PubMed  Google Scholar 

  28. Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121(1):20–7.

    Article  CAS  PubMed  Google Scholar 

  29. Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211(3):193–8.

    Article  CAS  PubMed  Google Scholar 

  30. Bowe WP, Logan AC. Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles. Lipids Health Dis. 2010;9:141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Elias PM, Brown BE, Ziboh VA. The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol. 1980;74(4):230–3.

    Article  CAS  PubMed  Google Scholar 

  32. Perisho K, Wertz PW, Madison KC, Stewart ME, Downing DT. Fatty acids of acylceramides from comedones and from the skin surface of acne patients and control subjects. J Invest Dermatol. 1988;90(3):350–3.

    Article  CAS  PubMed  Google Scholar 

  33. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, Voorhees JJ. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 2005;166(6):1691–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Thiboutot D. Regulation of human sebaceous glands. J Invest Dermatol. 2004;123(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  35. Kligman AM, Katz AG. Pathogenesis of acne vulgaris. I. Comedogenic properties of human sebum in external ear canal of the rabbit. Arch Dermatol. 1968;98(1):53–7.

    Article  CAS  PubMed  Google Scholar 

  36. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22(5):360–6.

    Article  PubMed  Google Scholar 

  37. Ottaviani M, Alestas T, Flori E, Mastrofrancesco A, Zouboulis CC, Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol. 2006;126(11):2430–7.

    Article  CAS  PubMed  Google Scholar 

  38. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001;117(1):44–51.

    Article  CAS  PubMed  Google Scholar 

  39. Dozsa A, Mihaly J, Dezso B, Csizmadia E, Keresztessy T, Marko L, Ruhl R, Remenyik E, Nagy L. Decreased peroxisome proliferator-activated receptor gamma level and signalling in sebaceous glands of patients with acne vulgaris. Clin Exp Dermatol. 2016;41(5):547–51.

    Article  CAS  PubMed  Google Scholar 

  40. Lim DT, James NM, Hassan S, Khan MA. Spondyloarthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: a review with illustrative cases. Curr Rheumatol Rep. 2013;15(8):346.

    Article  PubMed  Google Scholar 

  41. Graham GM, Farrar MD, Cruse-Sawyer JE, Holland KT, Ingham E. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol. 2004;150(3):421–8.

    Article  CAS  PubMed  Google Scholar 

  42. Yiu ZZ, Madan V, Griffiths CE. Acne conglobata and adalimumab: use of tumour necrosis factor-alpha antagonists in treatment-resistant acne conglobata, and review of the literature. Clin Exp Dermatol. 2014;40(4):383–6.

    Article  PubMed  Google Scholar 

  43. Grech I, Giatrakou S, Damoraki G, Pistiki A, Kaldrimidis P, Giamarellos-Bourboulis EJ, Stavrianeas N. Single nucleotide polymorphisms of toll-like receptor-4 protect against acne conglobata. J Eur Acad Dermatol Venereol. 2011;26(12):1538–43.

    PubMed  Google Scholar 

  44. Dessinioti C, Antoniou C, Katsambas A. Acneiform eruptions. Clin Dermatol. 2014;32(1):24–34.

    Article  PubMed  Google Scholar 

  45. Plewig G, Jansen T. Acneiform dermatoses. Dermatology. 1998;196(1):102–7.

    Article  CAS  PubMed  Google Scholar 

  46. Brunner MJ, Riddell Jr JM, Best WR. Cutaneous side effects of ACTH cortisone and pregnenolone therapy. J Invest Dermatol. 1951;16(4):205–10.

    Article  CAS  PubMed  Google Scholar 

  47. Du-Thanh A, Kluger N, Bensalleh H, Guillot B. Drug-induced acneiform eruption. Am J Clin Dermatol. 2011;12(4):233–45.

    Article  PubMed  Google Scholar 

  48. Sullivan M, Zeligman I. Acneform eruption due to corticotropin. AMA Arch Derm. 1956;73(2):133–41.

    Article  CAS  PubMed  Google Scholar 

  49. Chamaillard M, Mortemousque B, Boralevi F, Marques da Costa C, Aitali F, Taieb A, Leaute-Labreze C. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol. 2008;144(2):167–71.

    Article  PubMed  Google Scholar 

  50. Two AM, Del Rosso JQ. Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit. J Clin Aesthet Dermatol. 2014;7(1):20–5.

    PubMed  PubMed Central  Google Scholar 

  51. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol. 2001;117(1):91–7.

    Article  CAS  PubMed  Google Scholar 

  52. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111(11):1665–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975–80.

    Article  CAS  PubMed  Google Scholar 

  54. Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, Bonnart C, Descargues P, Hovnanian A, Gallo RL. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 2006;20(12):2068–80.

    Article  CAS  PubMed  Google Scholar 

  55. Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, Bradshaw M. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol. 2007;56(5):791–802.

    Article  PubMed  Google Scholar 

  56. Liu RH, Smith MK, Basta SA, Farmer ER. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol. 2006;142(8):1047–52.

    Article  CAS  PubMed  Google Scholar 

  57. Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T, Cogen AL, Gallo RL. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2010;131(3):688–97.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Larrick JW, Hirata M, Zhong J, Wright SC. Anti-microbial activity of human CAP18 peptides. Immunotechnology. 1995;1(1):65–72.

    Article  CAS  PubMed  Google Scholar 

  59. Wollina U. Recent advances in the understanding and management of rosacea. F1000Prime Rep. 2014;6:50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Thiele JJ, Schroeter C, Hsieh SN, Podda M, Packer L. The antioxidant network of the stratum corneum. Curr Probl Dermatol. 2001;29:26–42.

    Article  CAS  PubMed  Google Scholar 

  61. Gerber PA, Buhren BA, Steinhoff M, Homey B. Rosacea: the cytokine and chemokine network. J Investig Dermatol Symp Proc. 2011;15(1):40–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Zhang J, Xu X, Rao NV, Argyle B, McCoard L, Rusho WJ, Kennedy TP, Prestwich GD, Krueger G. Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea. PLoS One. 2011;6(2):e16658.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Del Rosso JQ. Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol. 2012;5(3):16–25.

    PubMed  PubMed Central  Google Scholar 

  64. Guzman-Sanchez DA, Ishiuji Y, Patel T, Fountain J, Chan YH, Yosipovitch G. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol. 2007;57(5):800–5.

    Article  PubMed  Google Scholar 

  65. Schwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, Rivier M, Carlavan I, Rossio P, Metze D, Buddenkotte J, Cevikbas F, Voegel JJ, Steinhoff M. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):53–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, Mess C, Cevikbas F, Rivier M, Carlavan I, Deret S, Rosignoli C, Metze D, Luger TA, Voegel JJ. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Smith JR, Lanier VB, Braziel RM, Falkenhagen KM, White C, Rosenbaum JT. Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol. 2007;91(2):226–9.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993;28(1):132–3.

    Article  CAS  PubMed  Google Scholar 

  69. Wollina U. Rhinophyma—unusual expression of simple-type keratins and S100A in sebocytes and abundance of VIP receptor-positive dermal cells. Histol Histopathol. 1996;11(1):111–5.

    CAS  PubMed  Google Scholar 

  70. Sulk M, Seeliger S, Aubert J, Schwab VD, Cevikbas F, Rivier M, Nowak P, Voegel JJ, Buddenkotte J, Steinhoff M. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. J Invest Dermatol. 2011;132(4):1253–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Kamada A, Saga K, Jimbow K. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. J Am Acad Dermatol. 2003;48(3):453–5.

    Article  PubMed  Google Scholar 

  72. Sandhu K, Gupta S, Kanwar AJ. Fox fordyce disease in a prepubertal girl. Pediatr Dermatol. 2005;22(1):89–90.

    Article  PubMed  Google Scholar 

  73. Ahmed Al-Qarqaz F, Al-Shannag R. Fox-Fordyce disease treatment with fractional CO2 laser. Int J Dermatol. 2013;52(12):1571–2.

    Article  PubMed  Google Scholar 

  74. Boer A. Patterns histopathologic of Fox-Fordyce disease. Am J Dermatopathol. 2004;26(6):482–92.

    Article  PubMed  Google Scholar 

  75. Brau Javier CN, Morales A, Sanchez JL. Histopathology attributes of Fox-Fordyce disease. Int J Dermatol. 2012;51(11):1313–8.

    Article  PubMed  Google Scholar 

  76. Yost J, Robinson M, Meehan SA. Fox-Fordyce disease. Dermatol Online J. 2012;18(12):28.

    PubMed  Google Scholar 

  77. Kao PH, Hsu CK, Lee JY. Clinicopathological study of Fox-Fordyce disease. J Dermatol. 2009;36(9):485–90.

    Article  PubMed  Google Scholar 

  78. Yost J, Robinson M, Meehan SA. Fox-Fordyce disease. Dermatol Online J. 2013;18(12):28.

    Google Scholar 

  79. Turner TW. Hormonal levels in Fox-Fordyce disease. Br J Dermatol. 1976;94(3):317–8.

    Article  CAS  PubMed  Google Scholar 

  80. Tetzlaff MT, Evans K, DeHoratius DM, Weiss R, Cotsarelis G, Elenitsas R. Fox-Fordyce disease following axillary laser hair removal. Arch Dermatol. 2011;147(5):573–6.

    Article  PubMed  Google Scholar 

  81. Gonzalez-Ramos J, Alonso-Pacheco ML, Goiburu-Chenu B, Mayor-Ibarguren A, Herranz-Pinto P. Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A. Br J Dermatol. 2015;174(2):458–9.

    Article  PubMed  Google Scholar 

  82. Sellheyer K, Krahl D. “Hidradenitis suppurativa” is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol. 2005;44(7):535–40.

    Article  PubMed  Google Scholar 

  83. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539–61; quiz 562-533.

    Article  PubMed  Google Scholar 

  84. Syed ZU, Hamzavi IH. Atypical hidradenitis suppurativa involving the posterior neck and occiput. Arch Dermatol. 2011;147(11):1343–4.

    Article  PubMed  Google Scholar 

  85. Boer J, Weltevreden EF. Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions. Br J Dermatol. 1996;135(5):721–5.

    Article  CAS  PubMed  Google Scholar 

  86. Buimer MG, Wobbes T, Klinkenbijl JH. Hidradenitis suppurativa. Br J Surg. 2009;96(4):350–60.

    Article  CAS  PubMed  Google Scholar 

  87. Kamp S, Fiehn AM, Stenderup K, Rosada C, Pakkenberg B, Kemp K, Dam TN, Jemec GB. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011;164(5):1017–22.

    Article  CAS  PubMed  Google Scholar 

  88. Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009;23(9):985–98.

    Article  CAS  PubMed  Google Scholar 

  89. Fismen S, Ingvarsson G, Moseng D, Nathalie Dufour D, Jorgensen L. A clinical-pathological review of hidradenitis suppurativa: using immunohistochemistry one disease becomes two. APMIS. 2012;120(6):433–40.

    Article  PubMed  Google Scholar 

  90. Boer J, Nazary M, Riis PT. The role of mechanical stress in Hidradenitis Suppurativa. Dermatol Clin. 2015;34(1):37–43.

    Article  CAS  Google Scholar 

  91. Kelly G, Prens EP. Inflammatory mechanisms in Hidradenitis Suppurativa. Dermatol Clin. 2015;34(1):51–8.

    Article  CAS  Google Scholar 

  92. Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell. 2009;16(5):633–47.

    Article  CAS  PubMed  Google Scholar 

  93. Pan Y, Lin MH, Tian X, Cheng HT, Gridley T, Shen J, Kopan R. gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev Cell. 2004;7(5):731–43.

    Article  CAS  PubMed  Google Scholar 

  94. Pink AE, Simpson MA, Desai N, Dafou D, Hills A, Mortimer P, Smith CH, Trembath RC, Barker JN. Mutations in the gamma-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa). J Invest Dermatol. 2012;132(10):2459–61.

    Article  CAS  PubMed  Google Scholar 

  95. Wang B, Yang W, Wen W, Sun J, Su B, Liu B, Ma D, Lv D, Wen Y, Qu T, Chen M, Sun M, Shen Y, Zhang X. Gamma-secretase gene mutations in familial acne inversa. Science. 2010;330(6007):1065.

    Article  CAS  PubMed  Google Scholar 

  96. Schlapbach C, Hanni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011;65(4):790–8.

    Article  CAS  PubMed  Google Scholar 

  97. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-alpha and IL-1beta. Br J Dermatol. 2011;164(6):1292–8.

    Article  PubMed  CAS  Google Scholar 

  98. Yazdanyar S, Jemec GB. Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis. 2010;24(2):118–23.

    Article  Google Scholar 

  99. Konig A, Lehmann C, Rompel R, Happle R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology. 1999;198(3):261–4.

    Article  CAS  PubMed  Google Scholar 

  100. Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831–9.

    Article  CAS  PubMed  Google Scholar 

  101. Woodruff CM, Charlie AM, Leslie KS. Hidradenitis suppurativa: a guide for the practicing physician. Mayo Clin Proc. 2015;90(12):1679–93.

    Article  PubMed  Google Scholar 

  102. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177–88; quiz 189–190.

    Article  CAS  PubMed  Google Scholar 

  103. Lew BL, Shin MK, Sim WY. Acute diffuse and total alopecia: a new subtype of alopecia areata with a favorable prognosis. J Am Acad Dermatol. 2009;60(1):85–93.

    Article  PubMed  Google Scholar 

  104. Dy LC, Whiting DA. Histopathology of alopecia areata, acute and chronic: why is it important to the clinician? Dermatol Ther. 2011;24(3):369–74.

    Article  PubMed  Google Scholar 

  105. Sperling LC, Winton GB. The transverse anatomy of androgenic alopecia. J Dermatol Surg Oncol. 1990;16(12):1127–33.

    Article  CAS  PubMed  Google Scholar 

  106. Peckham SJ, Sloan SB, Elston DM. Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates. J Am Acad Dermatol. 2011;65(3):615–20.

    Article  PubMed  Google Scholar 

  107. Whiting DA. Histopathologic features of alopecia areata: a new look. Arch Dermatol. 2003;139(12):1555–9.

    Article  PubMed  Google Scholar 

  108. Miteva M, Misciali C, Fanti PA, Tosti A. Histopathologic features of alopecia areata incognito: a review of 46 cases. J Cutan Pathol. 2012;39(6):596–602.

    Article  PubMed  Google Scholar 

  109. Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, Lambert J, Kruse R, Nothen MM. Familial aggregation of alopecia areata. J Am Acad Dermatol. 2006;54(4):627–32.

    Article  PubMed  Google Scholar 

  110. Muller SA, Winkelmann RK. Alopecia areata. An evaluation of 736 patients. Arch Dermatol. 1963;88:290–7.

    Article  CAS  PubMed  Google Scholar 

  111. Rodriguez TA, Fernandes KE, Dresser KL, Duvic M. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol. 2010;62(3):525–7.

    Article  PubMed  Google Scholar 

  112. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, Meyer KC, Paus R, Jahoda CA, Amos CI, Gregersen PK, Christiano AM. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;466(7302):113–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. McElwee KJ, Spiers EM, Oliver RF. In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata. Br J Dermatol. 1996;135(2):211–7.

    Article  CAS  PubMed  Google Scholar 

  114. Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med. 1993;66(6):541–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  115. Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2014;14(2):81–9.

    Article  PubMed  CAS  Google Scholar 

  116. Bertolini M, Uchida Y, Paus R. Toward the clonotype analysis of alopecia areata-specific, intralesional Human CD8+ T lymphocytes. J Investig Dermatol Symp Proc. 2015;17(2):9–12.

    Article  CAS  PubMed  Google Scholar 

  117. Castelo-Soccio L. Diagnosis and management of alopecia in children. Pediatr Clin North Am. 2014;61(2):427–42.

    Article  PubMed  Google Scholar 

  118. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol. 1996;35(6):899–906.

    Article  CAS  PubMed  Google Scholar 

  119. Malkud S. Telogen effluvium: a review. J Clin Diagn Res. 2015;9(9):WE01–3.

    PubMed  PubMed Central  Google Scholar 

  120. Shrivastava SB. Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009;75(1):20–7; quiz 27–28.

    Article  PubMed  Google Scholar 

  121. Sinclair R. Diffuse hair loss. Int J Dermatol. 1999;38 Suppl 1:8–18.

    Article  PubMed  Google Scholar 

  122. Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol. 1993;129(3):356–63.

    Article  CAS  PubMed  Google Scholar 

  123. Bittencourt C, Ferraro DA, Soares TC, Moraes AM, Cintra ML. Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis. Clin Exp Dermatol. 2014;39(8):868–73.

    Article  CAS  PubMed  Google Scholar 

  124. Choi M, Kim MS, Park SY, Park GH, Jo SJ, Cho KH, Lee JW, Park KD, Shin HY, Kang HJ, Kwon O. Clinical characteristics of chemotherapy-induced alopecia in childhood. J Am Acad Dermatol. 2014;70(3):499–505.

    Article  CAS  PubMed  Google Scholar 

  125. Tosi A, Misciali C, Piraccini BM, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf. 1994;10(4):310–7.

    Article  CAS  PubMed  Google Scholar 

  126. Kanwar AJ, Narang T. Anagen effluvium. Indian J Dermatol Venereol Leprol. 2013;79(5):604–12.

    Article  PubMed  Google Scholar 

  127. Sperling LC. Hair and systemic disease. Dermatol Clin. 2001;19(4):711–726, ix.

    Article  CAS  PubMed  Google Scholar 

  128. Sperling LC. Scarring alopecia and the dermatopathologist. J Cutan Pathol. 2001;28(7):333–42.

    Article  CAS  PubMed  Google Scholar 

  129. Vowels M, Chan LL, Giri N, Russell S, Lam-Po-Tang R. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant. 1993;12(4):347–50.

    CAS  PubMed  Google Scholar 

  130. Trueb RM. Chemotherapy-induced hair loss. Skin Therapy Lett. 2010;15(7):5–7.

    CAS  PubMed  Google Scholar 

  131. Autier J, Escudier B, Wechsler J, Spatz A, Robert C. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. Arch Dermatol. 2008;144(7):886–92.

    Article  CAS  PubMed  Google Scholar 

  132. Robert C, Mateus C, Spatz A, Wechsler J, Escudier B. Dermatologic symptoms associated with the multikinase inhibitor sorafenib. J Am Acad Dermatol. 2009;60(2):299–305.

    Article  PubMed  Google Scholar 

  133. Sofen H, Gross KG, Goldberg LH, Sharata H, Hamilton TK, Egbert B, Lyons B, Hou J, Caro I. A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma. J Am Acad Dermatol. 2015;73(1):99–105, e101.

    Article  CAS  PubMed  Google Scholar 

  134. Xie G, Wang H, Yan Z, Cai L, Zhou G, He W, Paus R, Yue Z. Testing chemotherapeutic agents in the feather follicle identifies a selective blockade of cell proliferation and a key role for sonic hedgehog signaling in chemotherapy-induced tissue damage. J Invest Dermatol. 2015;135(3):690–700.

    Article  CAS  PubMed  Google Scholar 

  135. Donovan JC, Ghazarian DM, Shaw JC. Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib. Arch Dermatol. 2008;144(11):1524–5.

    Article  PubMed  Google Scholar 

  136. Madke B, Gole P, Kumar P, Khopkar U. Dermatological side effects of epidermal growth factor receptor inhibitors: ‘PRIDE’ complex. Indian J Dermatol. 2014;59(3):271–4.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination. J Am Acad Dermatol. 2014;71(3):415 e411–15.

    Article  Google Scholar 

  138. Kim BJ, Kim JY, Eun HC, Kwon OS, Kim MN, Ro BI. Androgenetic alopecia in adolescents: a report of 43 cases. J Dermatol. 2006;33(10):696–9.

    Article  PubMed  Google Scholar 

  139. Stefanato CM. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology. 2010;56(1):24–38.

    Article  PubMed  Google Scholar 

  140. Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol. 1993;28(5 Pt 1):755–63.

    Article  CAS  PubMed  Google Scholar 

  141. Gonzalez ME, Cantatore-Francis J, Orlow SJ. Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients. Br J Dermatol. 2010;163(2):378–85.

    Article  CAS  PubMed  Google Scholar 

  142. Yim E, Nole KL, Tosti A. 5alpha-reductase inhibitors in androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes. 2014;21(6):493–8.

    Article  CAS  PubMed  Google Scholar 

  143. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998;39(4 Pt 1):578–89.

    Article  CAS  PubMed  Google Scholar 

  144. Ando Y, Yamaguchi Y, Hamada K, Yoshikawa K, Itami S. Expression of mRNA for androgen receptor, 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase in human dermal papilla cells. Br J Dermatol. 1999;141(5):840–5.

    Article  CAS  PubMed  Google Scholar 

  145. Hillmer AM, Freudenberg J, Myles S, Herms S, Tang K, Hughes DA, Brockschmidt FF, Ruan Y, Stoneking M, Nothen MM. Recent positive selection of a human androgen receptor/ectodysplasin A2 receptor haplotype and its relationship to male pattern baldness. Hum Genet. 2009;126(2):255–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  146. Sinclair R, Torkamani N, Jones L. Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. F1000Res. 2015;4(F1000 Faculty Rev):585.

    PubMed  PubMed Central  Google Scholar 

  147. Otberg N, Kang H, Alzolibani AA, Shapiro J. Folliculitis decalvans. Dermatol Ther. 2008;21(4):238–44.

    Article  PubMed  Google Scholar 

  148. Headington JT. Cicatricial alopecia. Dermatol Clin. 1996;14(4):773–82.

    Article  CAS  PubMed  Google Scholar 

  149. Mirmirani P, Willey A, Headington JT, Stenn K, McCalmont TH, Price VH. Primary cicatricial alopecia: histopathologic findings do not distinguish clinical variants. J Am Acad Dermatol. 2005;52(4):637–43.

    Article  PubMed  Google Scholar 

  150. Powell JJ, Dawber RP, Gatter K. Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol. 1999;140(2):328–33.

    Article  CAS  PubMed  Google Scholar 

  151. Douwes KE, Landthaler M, Szeimies RM. Simultaneous occurrence of folliculitis decalvans capillitii in identical twins. Br J Dermatol. 2000;143(1):195–7.

    Article  CAS  PubMed  Google Scholar 

  152. Fernandes JC, Correia TM, Azevedo F, Mesquita-Guimaraes J. Tufted hair folliculitis after scalp injury. Cutis. 2001;67(3):243–5.

    CAS  PubMed  Google Scholar 

  153. Kelly AP. Pseudofolliculitis barbae and acne keloidalis nuchae. Dermatol Clin. 2003;21(4):645–53.

    Article  PubMed  Google Scholar 

  154. Dinehart SM, Herzberg AJ, Kerns BJ, Pollack SV. Acne keloidalis: a review. J Dermatol Surg Oncol. 1989;15(6):642–7.

    Article  CAS  PubMed  Google Scholar 

  155. Herzberg AJ, Dinehart SM, Kerns BJ, Pollack SV. Acne keloidalis. Transverse microscopy, immunohistochemistry, and electron microscopy. Am J Dermatopathol. 1990;12(2):109–21.

    Article  CAS  PubMed  Google Scholar 

  156. Alexis A, Heath CR, Halder RM. Folliculitis keloidalis nuchae and pseudofolliculitis barbae: are prevention and effective treatment within reach? Dermatol Clin. 2014;32(2):183–91.

    Article  CAS  PubMed  Google Scholar 

  157. Ogunbiyi A, George A. Acne keloidalis in females: case report and review of literature. J Natl Med Assoc. 2005;97(5):736–8.

    PubMed  PubMed Central  Google Scholar 

  158. Madu P, Kundu RV. Follicular and scarring disorders in skin of color: presentation and management. Am J Clin Dermatol. 2014;15(4):307–21.

    Article  PubMed  Google Scholar 

  159. Salami T, Omeife H, Samuel S. Prevalence of acne keloidalis nuchae in Nigerians. Int J Dermatol. 2007;46(5):482–4.

    Article  PubMed  Google Scholar 

  160. Kline A, Relic J. Disseminate and recurrent infundibulofolliculitis in childhood: a rarely reported entity. Pediatr Dermatol. 2015;32(1):e5–7.

    Article  PubMed  Google Scholar 

  161. Owen WR, Wood C. Disseminate and recurrent infundibulofolliculitis. Arch Dermatol. 1979;115(2):174–5.

    Article  CAS  PubMed  Google Scholar 

  162. Nervi SJ, Schwartz RA, Dmochowski M. Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol. 2006;55(2):285–9.

    Article  PubMed  Google Scholar 

  163. Hernandez-Martin A, Nuno-Gonzalez A, Colmenero I, Torrelo A. Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol. 2013;68(1):150–5.

    Article  PubMed  Google Scholar 

  164. Ellis E, Scheinfeld N. Eosinophilic pustular folliculitis: a comprehensive review of treatment options. Am J Clin Dermatol. 2004;5(3):189–97.

    Article  PubMed  Google Scholar 

  165. Larralde M, Morales S, Santos Munoz A, Lamas F, Schroh R, Corbella C. Eosinophilic pustular folliculitis in infancy: report of two new cases. Pediatr Dermatol. 1999;16(2):118–20.

    Article  CAS  PubMed  Google Scholar 

  166. Razera F, Olm GS, Bonamigo RR. Neutrophilic dermatoses: part II. An Bras Dermatol. 2011;86(2):195–209; quiz 210–191.

    Article  PubMed  Google Scholar 

  167. Duarte AM, Kramer J, Yusk JW, Paller A, Schachner LA. Eosinophilic pustular folliculitis in infancy and childhood. Am J Dis Child. 1993;147(2):197–200.

    CAS  PubMed  Google Scholar 

  168. McCalmont TH, Altemus D, Maurer T, Berger TG. Eosinophilic folliculitis. The histologic spectrum. Am J Dermatopathol. 1995;17(5):439–46.

    Article  CAS  PubMed  Google Scholar 

  169. Takematsu H, Tagami H. Eosinophilic pustular folliculitis. Studies on possible chemotactic factors involved in the formation of pustules. Br J Dermatol. 1986;114(2):209–15.

    Article  CAS  PubMed  Google Scholar 

  170. Fearfield LA, Rowe A, Francis N, Bunker CB, Staughton RC. Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. Br J Dermatol. 1999;141(1):3–11.

    Article  CAS  PubMed  Google Scholar 

  171. Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pita O, Puddu P. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy. 2003;2(1):81–94.

    Article  CAS  PubMed  Google Scholar 

  172. Nunzi E, Parodi A, Rebora A. Ofuji’s disease: high circulating titers of IgG and IgM directed to basal cell cytoplasm. J Am Acad Dermatol. 1985;12(2 Pt 1):268–73.

    Article  CAS  PubMed  Google Scholar 

  173. Maruo K, Kayashima KI, Ono T. Expression of neuronal nitric oxide synthase in dermal infiltrated eosinophils in eosinophilic pustular folliculitis. Br J Dermatol. 1999;140(3):417–20.

    Article  CAS  PubMed  Google Scholar 

  174. Hernandez-Martin A, Nuno-Gonzalez A, Colmenero I, Torrelo A. Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol. 2012;68(1):150–5.

    Article  PubMed  Google Scholar 

  175. Alikhan A, Griffin J, Nguyen N, Davis DM, Gibson LE. Pediatric follicular mucinosis: presentation, histopathology, molecular genetics, treatment, and outcomes over an 11-year period at the Mayo Clinic. Pediatr Dermatol. 2013;30(2):192–8.

    Article  PubMed  Google Scholar 

  176. Santos-Briz A, Canueto J, Garcia-Dorado J, Alonso MT, Balanzategui A, Gonzalez-Diaz M. Pediatric primary follicular mucinosis: further evidence of its relationship with mycosis fungoides. Pediatr Dermatol. 2013;30(6):e218–20.

    Article  PubMed  Google Scholar 

  177. Zvulunov A, Shkalim V, Ben-Amitai D, Feinmesser M. Clinical and histopathologic spectrum of alopecia mucinosa/follicular mucinosis and its natural history in children. J Am Acad Dermatol. 2012;67(6):1174–81.

    Article  PubMed  Google Scholar 

  178. Brau-Javier CN, Santos-Arroyo AE, De Sanctis-Gonzalez IM, Sanchez JL. Follicular mucinosis presenting as an acneiform eruption: a follow-up study. Am J Dermatopathol. 2013;35(8):792–6.

    Article  PubMed  Google Scholar 

  179. Cerroni L, Fink-Puches R, Back B, Kerl H. Follicular mucinosis: a critical reappraisal of clinicopathologic features and association with mycosis fungoides and Sezary syndrome. Arch Dermatol. 2002;138(2):182–9.

    Article  PubMed  Google Scholar 

  180. Gibson LE, Muller SA, Leiferman KM, Peters MS. Follicular mucinosis: clinical and histopathologic study. J Am Acad Dermatol. 1989;20(3):441–6.

    Article  CAS  PubMed  Google Scholar 

  181. Nickoloff BJ, Wood C. Benign idiopathic versus mycosis fungoides-associated follicular mucinosis. Pediatr Dermatol. 1985;2(3):201–6.

    Article  CAS  PubMed  Google Scholar 

  182. Rongioletti F, De Lucchi S, Meyes D, Mora M, Rebora A, Zupo S, Cerruti G, Patterson JW. Follicular mucinosis: a clinicopathologic, histochemical, immunohistochemical and molecular study comparing the primary benign form and the mycosis fungoides-associated follicular mucinosis. J Cutan Pathol. 2010;37(1):15–9.

    Article  PubMed  Google Scholar 

  183. Hempstead RW, Ackerman AB. Follicular mucinosis. A reaction pattern in follicular epithelium. Am J Dermatopathol. 1985;7(3):245–57.

    Article  CAS  PubMed  Google Scholar 

  184. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Adult T-cell leukemia/lymphoma accompanying follicular mucinosis: a case report with review of the literature. Int J Clin Exp Pathol. 2013;6(12):3014–8.

    PubMed  PubMed Central  Google Scholar 

  185. Wada T, Yoshinaga E, Oiso N, Kawara S, Kawada A, Kozuka T. Adult T-cell leukemia-lymphoma associated with follicular mucinosis. J Dermatol. 2009;36(12):638–42.

    Article  PubMed  Google Scholar 

  186. Ishibashi A. Histogenesis of mucin in follicular mucinosis. An electron microscopic study. Acta Derm Venereol. 1976;56(3):163–71.

    CAS  PubMed  Google Scholar 

  187. Sah DE, Koo J, Price VH. Trichotillomania. Dermatol Ther. 2008;21(1):13–21.

    Article  PubMed  Google Scholar 

  188. Miteva M, Romanelli P, Tosti A. Pigmented casts. Am J Dermatopathol. 2014;36(1):58–63.

    Article  PubMed  Google Scholar 

  189. Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol. 2002;46(6):807–21; quiz 822-806.

    Article  PubMed  Google Scholar 

  190. Royer MC, Sperling LC. Splitting hairs: the ‘hamburger sign’ in trichotillomania. J Cutan Pathol. 2006;33 Suppl 2:63–4.

    Article  PubMed  Google Scholar 

  191. Chattopadhyay K. The genetic factors influencing the development of trichotillomania. J Genet. 2014;91(2):259–62.

    Google Scholar 

  192. Greer JM, Capecchi MR. Hoxb8 is required for normal grooming behavior in mice. Neuron. 2002;33(1):23–34.

    Article  CAS  PubMed  Google Scholar 

  193. Davies KE, Yesudian P. Pressure alopecia. Int J Trichology. 2012;4(2):64–8.

    Article  PubMed  PubMed Central  Google Scholar 

  194. Dominguez E, Eslinger MR, McCord SV. Postoperative (pressure) alopecia: report of a case after elective cosmetic surgery. Anesth Analg. 1999;89(4):1062–3.

    CAS  PubMed  Google Scholar 

  195. Wiles JC, Hansen RC. Postoperative (pressure) alopecia. J Am Acad Dermatol. 1985;12(1 Pt 2):195–8.

    Article  CAS  PubMed  Google Scholar 

  196. Kim GW, Park HJ, Kim HS, Kim SH, Ko HC, Kim MB, Kim BS. Bullae and sweat gland necrosis in the differential diagnosis for Vibrio vulnificus infection in an alcoholic patient. J Korean Med Sci. 2011;26(3):450–3.

    Article  PubMed  PubMed Central  Google Scholar 

  197. Hanly AJ, Jorda M, Badiavas E, Valencia I, Elgart GW. Postoperative pressure-induced alopecia: report of a case and discussion of the role of apoptosis in non-scarring alopecia. J Cutan Pathol. 1999;26(7):357–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology & Immunology, Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas, USA

    Thuy L. Phung MD, PhD

  2. Departments of Dermatology and Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA

    Teresa S. Wright MD

  3. Departments of Dermatology and Pediatrics, Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas, USA

    Crystal Y. Pourciau MD, MPH

  4. Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

    Bruce R. Smoller MD

Authors
  1. Thuy L. Phung MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa S. Wright MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Crystal Y. Pourciau MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruce R. Smoller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Phung, T.L., Wright, T.S., Pourciau, C.Y., Smoller, B.R. (2017). Inflammatory Disorders of the Cutaneous Appendages. In: Pediatric Dermatopathology. Springer, Cham. https://doi.org/10.1007/978-3-319-44824-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44824-4_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44822-0

  • Online ISBN: 978-3-319-44824-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation